Inhibition of human COT (66 to 395 residues) expressed in Sf21 cells using 5-Fluo-Ahx-AGAGSGQLIDSNleANSFVGTR-NH2 as substrate after 60 mins by caliper microfluidic mobility shift assay
Inhibition of COT in LPS-stimulated human PBMC assessed as reduction in ERK1/2 phosphorylation incubated for 60 mins followed by LPS stimulation for 12 mins by flow cytometric analysis
Inhibition of COT in LPS-stimulated human PBMC assessed as reduction in TNFalpha release incubated for 1 hr followed by stimulation with LPS for 4 hrs by HTRF assay
Inhibition of COT in LPS-stimulated human whole blood assessed as reduction in TNFalpha release incubated for 30 mins followed by stimulation with LPS for 3 hrs by HTRF assay
Half life in wild type Sprague-Dawley rat liver microsomes at 5 uM preincubated for 3 mins followed by NADPH addition measured after 1 hr by HPLC/MS analysis
Terminal elimination half life in beagle dog at 0.1 mg/kg, iv or 0.3 mg/kg, po fasted 12 hrs prior to compound administration via cassette dosing and fed 2 hrs post dose
Mean residence time in beagle dog at 0.1 mg/kg, iv or 0.3 mg/kg, po fasted 12 hrs prior to compound administration via cassette dosing and fed 2 hrs post dose